心脑血管病防治2024，Vol.24Issue(2)：24-30,7.DOI:10.3969/j.issn.1009-816x.2024.02.006
增强型体外反搏治疗慢性心力衰竭临床疗效的Meta分析
Clinical efficacy of enhanced external counterpulsation in the treatment of chronic heart failure:a Meta-analysis
李吉旭 1郭延林 2李允强 2李伟 2梁浩 1陆海楠3
作者信息
- 1. 210000 南京,南京中医药大学第一临床医学院心内科
- 2. 271000 泰安,山东省泰安市中医医院脑病科
- 3. 200000 上海,上海中医药大学附属龙华医院心内科
- 折叠
摘要
Abstract
Objective To evaluate the clinical efficacy of enhanced external counterpulsation(EECP)in the treatment of patients with chronic heart failure by meta-analysis.Methods Chinese(CNKI,Wanfang,VIP,SinoMed)and English(Cochrane Library,Embase,Web of Science,PubMed)databases were retrieved to collect randomized controlled trials(RCTs)of EECP in the treatment of chronic heart failure.After screening the literatures and extracting the data,meta-analysis was performed using Revman 5.4 software.Sensitivity analysis and subgroup analysis were used to assess the data and funnel plot was used to evaluate publication bias.Results A total of 14 RCTs involving 1 300 patients were included.Based on the clinical efficacy of different courses of EECP for chronic heart failure,the results showed that compared to the control group,patients in the observation group had longer 6-minute walk distance(6MWD)[MD(95%CI)=56.24(44.48-68.00),P<0.01],lower N-terminal pro-B-type natriuretic peptide(NT-proBNP)level[MD(95%CI)=-371.29(-642.63--99.95),P<0.01]and higher left ventricular ejection fraction(LVEF)level[MD(95%CI)=3.75(2.50-5.01),P<0.01]after treatment.There was no statistically significant difference in adverse reactions between the two groups[OR(95%CI)=1.62(0.69-3.76),P>0.05].Conclusion EECP therapy has good clinical efficacy,and is safe and reliable for patients with chronic heart failure.关键词
增强型体外反搏/慢性心力衰竭/Meta分析/有效性/安全性Key words
Enhanced external counterpulsation/Chronic heart failure/Meta-analysis/Efficacy/Safety引用本文复制引用
李吉旭,郭延林,李允强,李伟,梁浩,陆海楠..增强型体外反搏治疗慢性心力衰竭临床疗效的Meta分析[J].心脑血管病防治,2024,24(2):24-30,7.
